These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9683785)

  • 21. Variant CD44 expression by human fibroblasts.
    Rajarajan A; Bloor BK; Desai H; Stokes A; Odell EW
    Biomarkers; 2008 May; 13(3):307-18. PubMed ID: 18415803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
    Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
    Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines.
    Bloor BK; Jelvagharan M; White KN; Odell EW
    Int J Oncol; 2001 May; 18(5):1053-9. PubMed ID: 11295056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of variant CD44 epitopes in human astrocytic brain tumors.
    Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
    J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
    Yu Q; Toole BP
    J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
    Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
    Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
    Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
    Woodman AC; Sugiyama M; Yoshida K; Sugino T; Borgya A; Goodison S; Matsumura Y; Tarin D
    Am J Pathol; 1996 Nov; 149(5):1519-30. PubMed ID: 8909242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
    Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
    Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44 splice variants in metastatic and non-metastatic mouse tumour cell lines.
    Tkach T; Li E; Bestagno M; Burrone OR
    Immunol Lett; 1996 Sep; 52(2-3):81-7. PubMed ID: 8905400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia.
    Hale LP; Patel DD; Clark RE; Haynes BF
    J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein e expression in anaplastic thyroid carcinoma.
    Ito Y; Takano T; Miyauchi A
    Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.